Davis Polk & Wardwell

News About Davis Polk & Wardwell

Davis Polk adds Skadden’s global media deals chief in Los Angeles

Glen Mastroberte reunites with former Skadden partner Jason Russell, who launched Davis Polk's Los Angeles office in May

8 Oct 2026

Skadden, A&O Shearman, Davis Polk lead on $8.9bn Boots acquisition

Davis Polk guides Boots in deal that will see the retailer acquired by the Canadian branch of the Weston family, with Skadden and A&O Shearman across the table

7 Oct 2026

Gibson Dunn, Davis Polk steer Intel’s upsized $20bn stock offering

Gibson Dunn acts for Intel on first public share sale since 1971 as Davis Polk steers underwriters

11 Aug 2026

Davis Polk hires Hogan Lovells M&A chief ahead of merger

Longtime Hogan dealmaker Bill Curtin joins in Washington DC just days before his former firm combines with Cadwalader Wickersham & Taft

26 Jun 2026

Trio of firms guide GSK’s $10.6bn US cancer drug maker buy

Davis Polk and Slaughter and May advise GSK as Ropes & Gray counsels target Nuvalent

10 Jun 2026

Davis Polk launches Los Angeles office with longtime Skadden partner

New York firm’s first office in Southern California to be led by former Skadden litigator Jason Russell

1 May 2026

Davis Polk, Latham in for Klarna’s $1.4bn IPO as US listings rebound

Davis Polk guides Swedish fintech company’s much-anticipated listing on NYSE as Latham counsels underwriters

11 Sep 2025

Trio of top M&A firms guide CoreWeave’s $9bn Core Scientific AI acquisition

David Polk and Kirkland & Ellis advise CoreWeave as Wachtell Lipton Rosen & Katz acts for Core Scientific in deal to meet AI power needs

8 Jul 2025

Wachtell, Davis Polk lead $6.7bn merger of troubled drugmakers Mallinckrodt and Endo

Hogan Lovells, Paul Weiss and Ireland’s Arthur Cox and A&L Goodbody also act in tie-up of drugmakers with shared history of opioid crisis lawsuits

14 Mar 2025

Cravath, Davis Polk advise on Johnson & Johnson’s $14.6bn Intra-Cellular acquisition

Cravath advises longtime client J&J as it boosts key neurological drugs division

14 Jan 2025